废除G2/M检查点作为化剂的化学敏感化方法
Fengchao Lang1, James A Cornwell2, Karambir Kaur1
1Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
Neuro-oncology
|December 22, 2023
概括
通过抑制Myt1激酶来准细胞周期时间,使癌细胞对DNA损伤疗法如temozolomide (TMZ) 敏感. 这种方法迫使癌细胞与未经修复的DNA进行线粒分裂,从而导致细胞亡,并在临床前模型中改善了生存率.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 细胞周期检查点,特别是G2/M检查点,调节细胞分裂和DNA修复.
- 癌细胞利用G2/M检查点抵抗基因毒性化疗,促进分裂前的DNA修复.
- 调节细胞循环进展是一种有前途的策略,可以增强基于DNA损伤的癌症治疗.
研究的目的:
- 通过全基因组CRISPR/Cas9查,研究在基因毒性压力下瘤细胞生存的机制.
- 为了确定克服DNA损伤诱导癌症疗法的抗性新目标.
主要方法:
- 进行了全基因组的CRISPR/Cas9屏幕,并重复暴露于temozolomide (TMZ).
- 利用同位素分析来评估化剂和Myt1激酶抑制剂 (RP-6306) 之间的药物协同作用.
- 在携带质瘤的小鼠中进行了临床前动物研究.
主要成果:
- 鉴定出正规DNA修复途径 (ATM/Fanconi,不匹配修复) 对于在基因毒性压力下细胞命运至关重要.
- 确定PKMYT1对癌细胞存活至关重要;其枯竭使细胞对TMZ敏感.
- 用RP-6306与TMZ协同抑制Myt1激酶,诱导未经修复的DNA,线粒异常和亡的过早线粒分裂.
- TMZ和RP-6306的联合疗法在带质瘤的小鼠中延长了生存时间.
结论:
- 向Myt1激酶和细胞周期计时是一种可行的策略,可以提高基于DNA损伤的癌症疗法的疗效.
- 这种方法有可能改善患者在各种癌症,包括质瘤的结果.
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
DNA Damage can Stall the Cell Cycle
9.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K


